Profil
Stephen A.
Moglia worked as the Chief Accounting Officer & Vice President at Orexigen Therapeutics, Inc. from 2018 to 2018.
Prior to that, he attended San Diego State University for his undergraduate degree.
Anciens postes connus de Stephen A. Moglia
| Sociétés | Poste | Fin |
|---|---|---|
| OREXIGEN THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 27/07/2018 |
Formation de Stephen A. Moglia
| San Diego State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |